Literature DB >> 15015023

New formulation of BOTOX. Complete antibody-induced therapy failure in hemifacial spasm.

Dirk Dressler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015023     DOI: 10.1007/s00415-004-0347-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.

Authors:  D Dressler; F Adib Saberi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

2.  New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.

Authors:  D Dressler; F Adib Saberi
Journal:  BMJ Case Rep       Date:  2009-01-23

3.  Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.

Authors:  Dirk Dressler; Hans Bigalke
Journal:  J Neurol       Date:  2005-03-11       Impact factor: 4.849

4.  [Essential blepharospasm : Practice-oriented therapy with botulinum toxin employing reduced treatment intervals].

Authors:  B Wabbels; P Roggenkämper
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

5.  Safety aspects of incobotulinumtoxinA high-dose therapy.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Katja Kollewe; Christoph Schrader
Journal:  J Neural Transm (Vienna)       Date:  2014-07-17       Impact factor: 3.575

6.  Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors:  Jürgen Frevert; Dirk Dressler
Journal:  Biologics       Date:  2010-12-09

7.  Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production.

Authors:  Rungsima Wanitphakdeedecha; Watsachon Kantaviro; Panittra Suphatsathienkul; Ploypailin Tantrapornpong; Chadakan Yan; Chalermkwan Apinumtham; Yuttana Srinoulprasert
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-22

8.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

9.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.